SCHEDULE 13G/A: FMR LLC and Abigail P. Johnson Disclose 10.0% Stake in ARGENX SE
Beneficial Ownership Report (Schedule 13G Amendment)
FMR LLC and its Chairman and CEO, Abigail P. Johnson, have filed an amended Schedule 13G, reporting a beneficial ownership of 10.0% in ARGENX SE's common stock as of December 31, 2024.
Summary
- FMR LLC and Abigail P. Johnson, as reporting persons, collectively beneficially own 6,019,640.29 shares of ARGENX SE common stock.
- This aggregate amount represents 10.0% of the outstanding common stock of ARGENX SE.
- FMR LLC holds sole voting power over 5,708,605.90 shares and sole dispositive power over 6,019,640.29 shares.
- Abigail P. Johnson, through her association with FMR LLC, is deemed to have sole dispositive power over 6,019,640.29 shares, but no sole or shared voting power.
- The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of ARGENX SE.
- FMR LLC is classified as a parent holding company (HC), and Abigail P. Johnson is classified as an individual (IN).
- Several FMR LLC subsidiaries and affiliates, including Fidelity Management & Research Company LLC, are identified as entities that beneficially own shares, with Fidelity Management & Research Company LLC owning 5% or greater of the outstanding shares.
Sentiment
Score: 5
Explanation: The document is a factual report of beneficial ownership and does not contain information that would inherently lead to a positive or negative sentiment regarding the issuer's performance. The sentiment is neutral as it simply states a significant ownership stake by a large institutional investor.
Positives
- The significant 10.0% stake held by a major institutional investor like FMR LLC could signal confidence in ARGENX SE's long-term prospects.
- The filing indicates that the shares are held in the ordinary course of business, suggesting a passive investment rather than an activist intent to influence control.
Negatives
- The document does not contain information that would typically be considered negative regarding ARGENX SE's operational or financial performance, as it is a beneficial ownership report.
Risks
- The document does not detail specific risks related to ARGENX SE's business operations or financial health, as it is a beneficial ownership filing focused on shareholding structure.
Future Outlook
This Schedule 13G filing does not contain any forward-looking statements or guidance regarding ARGENX SE's future performance or outlook. It solely reports beneficial ownership as of a specific date.
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11." (Certification by FMR LLC and Abigail P. Johnson)
Industry Context
This filing is a routine disclosure by a major asset manager, FMR LLC (Fidelity), indicating its significant passive investment in ARGENX SE. Such large institutional holdings are common in the biotechnology and pharmaceutical sectors, reflecting long-term investment strategies in companies with promising pipelines or market positions.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director, Chairman, and Chief Executive Officer of FMR LLC | N/A | Abigail P. Johnson | N/A | Abigail P. Johnson's role at FMR LLC is noted as part of her beneficial ownership disclosure, not a change. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Governance Structure Disclosure | The document discloses that members of the Johnson family, including Abigail P. Johnson, are predominant owners of Series B voting common shares of FMR LLC (49% voting power) and have a shareholders' voting agreement to vote Series B shares in accordance with the majority vote. This structure allows the Johnson family to be deemed a controlling group with respect to FMR LLC under the Investment Company Act of 1940. | N/A (existing structure) | This provides transparency into the control structure of FMR LLC, the reporting entity, but does not directly impact ARGENX SE's corporate governance. |
Stakeholder Impact
- Shareholders: The disclosure of a significant 10.0% stake by FMR LLC may be viewed positively by other shareholders as it indicates strong institutional interest and potential long-term commitment to ARGENX SE.
- Investment Professionals: Provides updated information on institutional ownership, which is crucial for market analysis and understanding the shareholder base of ARGENX SE.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires the filing of this statement (reporting period end date). |
| 02/11/2025 | Date the Schedule 13G Amendment No. 11 was signed and filed. |
Keywords
ARGENX SE, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Equity Stake, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.